Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Reassignment Surgery | 23 | 2024 | 41 | 11.940 |
Why?
|
| Transgender Persons | 19 | 2024 | 107 | 8.140 |
Why?
|
| Transsexualism | 13 | 2023 | 34 | 6.340 |
Why?
|
| Surgeons | 6 | 2024 | 248 | 2.430 |
Why?
|
| Face | 4 | 2023 | 116 | 1.800 |
Why?
|
| Penis | 4 | 2021 | 60 | 1.420 |
Why?
|
| Feminization | 2 | 2019 | 2 | 1.340 |
Why?
|
| Postoperative Complications | 5 | 2024 | 2283 | 1.250 |
Why?
|
| Surgery, Plastic | 5 | 2023 | 42 | 1.220 |
Why?
|
| Gender Dysphoria | 3 | 2022 | 9 | 1.180 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 3013 | 1.010 |
Why?
|
| Breast Implantation | 1 | 2024 | 14 | 0.940 |
Why?
|
| Breast Implants | 1 | 2024 | 26 | 0.920 |
Why?
|
| Cheek | 2 | 2023 | 22 | 0.880 |
Why?
|
| Patient Satisfaction | 5 | 2022 | 460 | 0.870 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 428 | 0.870 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 53 | 0.830 |
Why?
|
| Surgical Flaps | 3 | 2021 | 249 | 0.820 |
Why?
|
| Humans | 54 | 2024 | 89391 | 0.810 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 116 | 0.790 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 200 | 0.760 |
Why?
|
| Hormones | 1 | 2021 | 139 | 0.720 |
Why?
|
| Female | 30 | 2024 | 46238 | 0.710 |
Why?
|
| Venous Thromboembolism | 2 | 2021 | 159 | 0.710 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 67 | 0.700 |
Why?
|
| Mastectomy | 4 | 2023 | 246 | 0.700 |
Why?
|
| Insurance Coverage | 1 | 2021 | 120 | 0.690 |
Why?
|
| Male | 25 | 2024 | 42434 | 0.640 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2018 | 14 | 0.620 |
Why?
|
| Telemedicine | 1 | 2021 | 188 | 0.610 |
Why?
|
| Sex Reassignment Procedures | 1 | 2017 | 4 | 0.590 |
Why?
|
| Nipples | 1 | 2015 | 37 | 0.490 |
Why?
|
| Education, Medical | 1 | 2017 | 243 | 0.460 |
Why?
|
| Quality of Life | 2 | 2023 | 1669 | 0.450 |
Why?
|
| Peer Review | 2 | 2022 | 23 | 0.400 |
Why?
|
| Internship and Residency | 2 | 2023 | 1048 | 0.390 |
Why?
|
| Gender Identity | 2 | 2023 | 53 | 0.390 |
Why?
|
| Genitalia | 2 | 2022 | 21 | 0.390 |
Why?
|
| Prostheses and Implants | 3 | 2023 | 124 | 0.370 |
Why?
|
| Wound Healing | 2 | 2023 | 359 | 0.370 |
Why?
|
| Phenylephrine | 1 | 2010 | 36 | 0.360 |
Why?
|
| Drug Labeling | 1 | 2010 | 41 | 0.350 |
Why?
|
| Medication Errors | 1 | 2010 | 39 | 0.350 |
Why?
|
| Emotions | 2 | 2023 | 349 | 0.350 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 192 | 0.350 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 56 | 0.340 |
Why?
|
| Vagina | 2 | 2021 | 174 | 0.340 |
Why?
|
| Rhinoplasty | 1 | 2010 | 35 | 0.340 |
Why?
|
| Patient-Centered Care | 2 | 2022 | 207 | 0.340 |
Why?
|
| Urethra | 2 | 2020 | 115 | 0.310 |
Why?
|
| Mucormycosis | 1 | 2008 | 15 | 0.300 |
Why?
|
| Maxillary Sinus | 1 | 2008 | 26 | 0.300 |
Why?
|
| Mental Health | 3 | 2023 | 178 | 0.290 |
Why?
|
| Skull | 2 | 2019 | 255 | 0.290 |
Why?
|
| Fibromatosis, Gingival | 1 | 2006 | 1 | 0.280 |
Why?
|
| United States | 8 | 2024 | 6999 | 0.250 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2024 | 60 | 0.240 |
Why?
|
| Acellular Dermis | 1 | 2023 | 5 | 0.230 |
Why?
|
| Facial Bones | 1 | 2023 | 37 | 0.220 |
Why?
|
| Vocal Cords | 1 | 2023 | 28 | 0.220 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 84 | 0.220 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 420 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3448 | 0.210 |
Why?
|
| Hyperplasia | 1 | 2022 | 152 | 0.210 |
Why?
|
| Mammaplasty | 1 | 2024 | 110 | 0.210 |
Why?
|
| Endoscopy | 2 | 2023 | 351 | 0.210 |
Why?
|
| Voice | 1 | 2022 | 20 | 0.200 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 20 | 0.200 |
Why?
|
| Physician Incentive Plans | 1 | 2021 | 20 | 0.200 |
Why?
|
| Reimbursement, Incentive | 1 | 2021 | 37 | 0.200 |
Why?
|
| Fee-for-Service Plans | 1 | 2021 | 30 | 0.190 |
Why?
|
| San Francisco | 1 | 2021 | 24 | 0.190 |
Why?
|
| Medicare | 2 | 2024 | 425 | 0.190 |
Why?
|
| Perioperative Period | 1 | 2021 | 25 | 0.190 |
Why?
|
| Peritoneum | 1 | 2021 | 57 | 0.190 |
Why?
|
| Infertility, Female | 1 | 2021 | 97 | 0.190 |
Why?
|
| Health Personnel | 1 | 2023 | 215 | 0.180 |
Why?
|
| Clitoris | 1 | 2020 | 4 | 0.180 |
Why?
|
| Estrogens | 1 | 2021 | 201 | 0.170 |
Why?
|
| Skin Transplantation | 1 | 2021 | 184 | 0.170 |
Why?
|
| Dermal Fillers | 1 | 2019 | 3 | 0.170 |
Why?
|
| Cephalometry | 1 | 2019 | 50 | 0.170 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 148 | 0.160 |
Why?
|
| Rhytidoplasty | 1 | 2019 | 12 | 0.160 |
Why?
|
| Penile Implantation | 1 | 2019 | 14 | 0.160 |
Why?
|
| Penile Prosthesis | 1 | 2019 | 24 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2009 | 74 | 0.160 |
Why?
|
| Incidence | 2 | 2021 | 1597 | 0.160 |
Why?
|
| Aging | 2 | 2023 | 718 | 0.160 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 588 | 0.150 |
Why?
|
| Organ Transplantation | 1 | 2021 | 276 | 0.150 |
Why?
|
| Medicaid | 1 | 2021 | 232 | 0.150 |
Why?
|
| Social Media | 1 | 2019 | 95 | 0.150 |
Why?
|
| Young Adult | 3 | 2024 | 6317 | 0.140 |
Why?
|
| Sex Characteristics | 1 | 2019 | 326 | 0.140 |
Why?
|
| Heart | 1 | 2019 | 574 | 0.130 |
Why?
|
| Contrast Media | 2 | 2015 | 1092 | 0.120 |
Why?
|
| Mammary Arteries | 1 | 2015 | 34 | 0.120 |
Why?
|
| Chin | 1 | 2014 | 8 | 0.120 |
Why?
|
| Wounds, Stab | 1 | 2014 | 10 | 0.120 |
Why?
|
| Graphite | 1 | 2014 | 12 | 0.120 |
Why?
|
| Adult | 5 | 2024 | 26631 | 0.120 |
Why?
|
| Societies, Medical | 2 | 2021 | 578 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2020 | 9060 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1048 | 0.110 |
Why?
|
| Foreign Bodies | 1 | 2014 | 66 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2020 | 2873 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2012 | 89 | 0.100 |
Why?
|
| Middle Aged | 7 | 2024 | 25995 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 125 | 0.090 |
Why?
|
| Hematologic Diseases | 1 | 2009 | 78 | 0.080 |
Why?
|
| Patient Selection | 2 | 2009 | 684 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1714 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2021 | 8247 | 0.080 |
Why?
|
| Phosphatidylglycerols | 1 | 2008 | 5 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2008 | 34 | 0.080 |
Why?
|
| Phosphatidylcholines | 1 | 2008 | 49 | 0.080 |
Why?
|
| Drug Combinations | 1 | 2008 | 203 | 0.070 |
Why?
|
| Evidence-Based Medicine | 3 | 2021 | 433 | 0.070 |
Why?
|
| Infliximab | 1 | 2008 | 159 | 0.070 |
Why?
|
| Antifungal Agents | 1 | 2008 | 120 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2008 | 170 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 170 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2012 | 2305 | 0.060 |
Why?
|
| Pedigree | 1 | 2006 | 970 | 0.060 |
Why?
|
| Aged | 4 | 2024 | 19178 | 0.060 |
Why?
|
| Thyroid Cartilage | 1 | 2023 | 1 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2003 | 37 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 93 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 85 | 0.050 |
Why?
|
| Portal Vein | 1 | 2002 | 120 | 0.050 |
Why?
|
| Strategic Planning | 1 | 2021 | 2 | 0.050 |
Why?
|
| Hepatic Artery | 1 | 2002 | 84 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 124 | 0.050 |
Why?
|
| Efficiency | 1 | 2021 | 40 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 1412 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 357 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 263 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2021 | 181 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2021 | 151 | 0.050 |
Why?
|
| Forecasting | 1 | 2021 | 306 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2021 | 312 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 222 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 1999 | 17 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 469 | 0.040 |
Why?
|
| Thrombosis | 1 | 2002 | 302 | 0.040 |
Why?
|
| Penile Erection | 1 | 2019 | 22 | 0.040 |
Why?
|
| Safety | 2 | 2009 | 149 | 0.040 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 49 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 568 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 417 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 479 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2023 | 785 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 1999 | 277 | 0.040 |
Why?
|
| Burns | 1 | 1999 | 141 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2002 | 1170 | 0.030 |
Why?
|
| Facial Injuries | 1 | 2014 | 19 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 9268 | 0.030 |
Why?
|
| Lacerations | 1 | 2014 | 27 | 0.030 |
Why?
|
| Skin | 1 | 2014 | 583 | 0.020 |
Why?
|
| Child | 2 | 2014 | 7175 | 0.020 |
Why?
|
| Intermittent Claudication | 1 | 1987 | 20 | 0.020 |
Why?
|
| Microspheres | 1 | 2003 | 108 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2003 | 72 | 0.010 |
Why?
|
| Albumins | 1 | 2003 | 129 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 200 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 198 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 704 | 0.010 |
Why?
|
| Tuberculosis, Hepatic | 1 | 1981 | 2 | 0.010 |
Why?
|
| Anthropometry | 1 | 1999 | 75 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1999 | 80 | 0.010 |
Why?
|
| Animals | 2 | 2012 | 27387 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 3161 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 3733 | 0.010 |
Why?
|
| Neoplasms | 1 | 1987 | 3043 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 1987 | 21 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1987 | 730 | 0.000 |
Why?
|
| Angiography | 1 | 1981 | 208 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1987 | 1198 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1981 | 394 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1981 | 1597 | 0.000 |
Why?
|
| Liver | 1 | 1981 | 1208 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1981 | 759 | 0.000 |
Why?
|